Cytori Therapeutics reported $32K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Baxter International BAX:US USD 683M 0
Cerus CERS:US USD 177K 0
Cytori Therapeutics CYTX:US USD 32K 10K
Genocea Biosciences GNCA:US USD 59K 1000
Haemonetics HAE:US USD 506K 7K
Infinity Pharmaceuticals INFI:US USD 89K 0
Mirati Therapeutics MRTX:US USD 58K 2K
Northwest Biotherapeutics NWBO:US USD 1.05M 17K
Starpharma Holdings Ltd SPL:AU AUD 240.67M 39K
Teva Pharmaceutical TEVA:IT USD 20.31B 387.03M